Diabetes is very common in people living in post-acute and long-term environments, affecting 25% to 34% of these individuals.

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

About 2 million Americans with Type 1 diabetes must take the medication to regulate their blood sugar because their bodies do not produce insulin. Millions more with Type 2 diabetes also take ...

We couldn’t be happier to see Dr Sheila Reith, CBE honoured at the Pride of Britain Awards for improving the lives of millions of people with diabetes worldwide.

A beloved former Stirling doctor, who transformed the lives of millions of people with diabetes after co-inventing the world’s first insulin pen, has been honoured with the Mirror Pride of ...

Life with diabetes usually includes many injections of the blood sugar–controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit ...

Background: Development of hyperglycemia during hospitalization is an area of concern in patients with and without diabetes mellitus ... To compare traditional sliding scale (SS) with a tight ...

SS patients who received oral hypoglycemics, insulin aspart mix, insulin detemir, insulin glargine, insulin glulisine, insulin NPH, or insulin 70/30; or TC patients who received oral hypoglycemics ...

Now, scientists have made a major breakthrough in developing what has been long called the “holy grail” diabetes treatments — a “smart” insulin that responds in real time to fluctuations in one’s ...

A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...